Real‐world data on patterns and outcomes of radiation therapy for brain metastases in a population‐based cohort of lung cancer patients in Victoria

We evaluated real‐world data on the patterns and outcomes of radiotherapy (RT) for brain metastases (BM) in a population‐based cohort of patients with lung cancer (LC) in Victoria.

[1]  A. Sahgal,et al.  Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis. , 2022, The Lancet. Oncology.

[2]  Manali I. Patel,et al.  The evolving landscape of sex-based differences in lung cancer: a distinct disease in women , 2022, European Respiratory Review.

[3]  B. Hickey,et al.  Defining the expected 30-day mortality for patients undergoing palliative radiotherapy: a meta-analysis. , 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  Ma Yi,et al.  30‐day mortality following palliative radiotherapy , 2020, Journal of medical imaging and radiation oncology.

[5]  Derek E. Smith,et al.  Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study. , 2020, JAMA oncology.

[6]  R. Milne,et al.  Stereotactic radiosurgery for managing brain metastases in Victoria, 2012–2017 , 2020, The Medical journal of Australia.

[7]  N. Hanna,et al.  Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  I. Fraser,et al.  Patterns of Radiotherapy Utilization for Lung Cancer Patients with Brain Metastases: A Population-based Analysis , 2019, Cureus.

[9]  J. Ruben,et al.  Contemporary practice patterns of stereotactic radiosurgery for brain metastasis: A review of published Australian literature , 2019, Journal of medical imaging and radiation oncology.

[10]  R. Williamson,et al.  Management of brain metastases from large cell neuroendocrine carcinoma of the lung: improved outcomes with radiosurgery , 2019, Acta oncologica.

[11]  M. Elshaikh,et al.  Disparities in the Use of Single-fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases From Non-small Cell Lung Cancer , 2019, Cureus.

[12]  Wei Jiang,et al.  Stereotactic radiosurgery for brain metastases from newly diagnosed small cell lung cancer: practice patterns and outcomes , 2019, Acta oncologica.

[13]  A. Amini,et al.  Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer. , 2018, Lung cancer.

[14]  S. Alibhai,et al.  Use of Comprehensive Geriatric Assessment and Geriatric Screening for Older Adults in the Radiation Oncology Setting: A Systematic Review. , 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

[15]  B. Kann,et al.  Radiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United States. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[16]  M. Gould,et al.  Radiotherapy for brain metastases near the end of life in an integrated health care system. , 2017, Annals of Palliative Medicine.

[17]  S. Gettinger,et al.  Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Ruth E Langley,et al.  Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial , 2016, The Lancet.

[19]  Volker W Stieber,et al.  Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. , 2016, JAMA.

[20]  S. Gettinger,et al.  Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases. , 2016, International journal of radiation oncology, biology, physics.

[21]  A. Newsham,et al.  30 day mortality in adult palliative radiotherapy – A retrospective population based study of 14,972 treatment episodes , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  J. Beyene,et al.  Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. , 2015, International journal of radiation oncology, biology, physics.

[23]  Satoshi Suzuki,et al.  Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. , 2014, The Lancet. Oncology.

[24]  J. Weeks,et al.  Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States. , 2013, International journal of radiation oncology, biology, physics.

[25]  C. Ménard,et al.  A multi-institutional study of factors influencing the use of stereotactic radiosurgery for brain metastases. , 2013, International journal of radiation oncology, biology, physics.

[26]  P. Wen,et al.  Epidemiology of Brain Metastases , 2012, Current Oncology Reports.

[27]  K. Hess,et al.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. , 2009, The Lancet. Oncology.

[28]  Maria Werner-Wasik,et al.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.

[29]  Per Capita,et al.  About the authors , 1995, Machine Vision and Applications.

[30]  E. Rakovitch,et al.  Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. , 2018, The Cochrane database of systematic reviews.

[31]  L. Collette,et al.  A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  T. Buchholz,et al.  Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.